BSE
524280

Kopran Limited

Other
Other

Prices are adjusted according to historical splits.

Kopran Limited Stock Price

Vitals

Today's Low:
₹208.6
Today's High:
₹235.4
Open Price:
₹231.35
52W Low:
₹96
52W High:
₹252.35
Prev. Close:
₹231.8
Volume:
156606

Company Statistics

Market Cap.:
₹5.14 billion
Book Value:
50.907
Revenue TTM:
₹4.27 billion
Operating Margin TTM:
14.22%
Gross Profit TTM:
₹1.47 billion
Profit Margin:
9.82%
Return on Assets TTM:
10.06%
Return on Equity TTM:
21.06%

Company Profile

Kopran Limited had its IPO on under the ticker symbol 524280.

The company operates in the Other sector and Other industry. Kopran Limited has a staff strength of 0 employees.

Stock update

Shares of Kopran Limited opened at ₹231.35 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹208.6 - ₹235.4, and closed at ₹213.85.

This is a -7.74% slip from the previous day's closing price.

A total volume of 156,606 shares were traded at the close of the day’s session.

In the last one week, shares of Kopran Limited have slipped by -9.93%.

Kopran Limited's Key Ratios

Kopran Limited has a market cap of ₹5.14 billion, indicating a price to book ratio of 2.4493 and a price to sales ratio of 1.2653.

In the last 12-months Kopran Limited’s revenue was ₹4.27 billion with a gross profit of ₹1.47 billion and an EBITDA of ₹706.84 million. The EBITDA ratio measures Kopran Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Kopran Limited’s operating margin was 14.22% while its return on assets stood at 10.06% with a return of equity of 21.06%.

In Q3, Kopran Limited’s quarterly earnings growth was a positive 193.1% while revenue growth was a positive 35.6%.

Kopran Limited’s PE and PEG Ratio

Forward PE
0
Trailing PE
12.8711
PEG

Its diluted EPS in the last 12-months stands at ₹9.699 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Kopran Limited’s profitability.

Kopran Limited stock is trading at a EV to sales ratio of 1.398 and a EV to EBITDA ratio of 8.1709. Its price to sales ratio in the trailing 12-months stood at 1.2653.

Kopran Limited stock pays annual dividends of ₹1.5 per share, indicating a yield of 1.2% and a payout ratio of 17.45%.

Balance sheet and cash flow metrics

Total Assets
₹6.50 billion
Total Liabilities
₹1.77 billion
Operating Cash Flow
₹-126504000.00
Capital Expenditure
₹610.45 million
Dividend Payout Ratio
17.45%

Kopran Limited ended 2024 with ₹6.50 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹6.50 billion while shareholder equity stood at ₹4.39 billion.

Kopran Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹1.77 billion in other current liabilities, 482116000.00 in common stock, ₹3.91 billion in retained earnings and ₹58000.00 in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹126.51 million. The company’s total short-term debt was ₹573,461,000 while long-term debt stood at ₹178.92 million.

Kopran Limited’s total current assets stands at ₹3.99 billion while long-term investments were ₹0 and short-term investments were ₹711000.00. Its net receivables were ₹1.63 billion compared to accounts payable of ₹0 and inventory worth ₹1.31 billion.

In 2024, Kopran Limited's operating cash flow was ₹-126504000.00 while its capital expenditure stood at ₹610.45 million.

Comparatively, Kopran Limited paid ₹0.17 in dividends in 2024.

Other key metrics

Current Trading Price
₹213.85
52-Week High
₹252.35
52-Week Low
₹96
Analyst Target Price

Kopran Limited stock is currently trading at ₹213.85 per share. It touched a 52-week high of ₹252.35 and a 52-week low of ₹252.35. Analysts tracking the stock have a 12-month average target price of .

Its 50-day moving average was ₹192.29 and 200-day moving average was ₹154.86 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 3934.6% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Kopran Limited

The stock symbol (also called stock or share ticker) of Kopran Limited is 524280

The IPO of Kopran Limited took place on

Similar Industry Stocks (Other)

Last Price
Chg
Chg%
₹36.1
-3.91
-9.77%
₹25.79
0.36
+1.42%
₹11.57
-0.05
-0.43%
₹1552.25
-81.65
-5%
₹0.02
0.01
+58%
Ggtoor Inc (GTOR)
₹0
0
0%
₹167.75
-8.8
-4.98%
₹0.17
0.01
+6.96%
₹131.55
-4.7
-3.45%
₹19.94
0.07
+0.35%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
₹0.14
0.07
+100%
₹0.12
0.04
+45.29%
₹0.96
0.05
+5.4%
₹1.34
-0.35
-20.71%
Humbl Inc (HMBL)
₹0
0
0%

Top Gainers

Last Price
Chg
Chg%
₹0
0
+172200%
₹0
0
+51200%
₹283
280.03
+9428.62%
₹11.2
10.57
+1667.68%
Latch Inc (LTCHW)
₹0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
₹0.19
-123.15
-99.85%
₹0
-0.11
-99.55%
₹0
-0
-97.96%
₹0
-0.01
-93.94%
₹0.01
-0.06
-92.24%

About

Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers finished dosage forms, including tablets, capsules, dry powder, suspension, and injectable in various therapeutic areas comprising cardiovascular, gastrointestinal, pain management, oncology, anti-allergic, central nervous system, erectile dysfunction, and others, as well as antibiotics, anti-diabetic, respiratory, anthelmentics, antiprotozoals, and antipeptic ulcer and gut. It also provides active pharmaceutical ingredients in the categories of anti-hypertensive, macrolide, neuromodulator, sterile cephalosporins, carbapenems, anti-acne, anti-ulcerant, anti-depressent, anti-infective, urological, and anti-thrombotic. The company was incorporated in 1958 and is headquartered in Mumbai, India.

Address

Parijat House, Mumbai, India, 400018